Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Gains from Investment Securities (2020 - 2025)

Foghorn Therapeutics has reported Gains from Investment Securities over the past 4 years, most recently at $1000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $1000.0 for Q4 2025, down 97.87% from a year ago — trailing twelve months through Dec 2025 was $9000.0 (down 98.95% YoY), and the annual figure for FY2025 was $9000.0, down 98.95%.
  • Gains from Investment Securities for Q4 2025 was $1000.0 at Foghorn Therapeutics, down from $4000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for FHTX hit a ceiling of $1.7 million in Q2 2023 and a floor of $1000.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 3 years was $54000.0 (2024), compared with a mean of $442000.0.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 58.28% in 2024 and later plummeted 99.43% in 2025.
  • Foghorn Therapeutics' Gains from Investment Securities stood at $865000.0 in 2023, then tumbled by 94.57% to $47000.0 in 2024, then crashed by 97.87% to $1000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $1000.0 (Q4 2025), $4000.0 (Q2 2025), and $4000.0 (Q1 2025) per Business Quant data.